AxoGen - 34 Year Stock Price History | AXGN
- The all-time high AxoGen stock closing price was 55.90 on July 23, 2018.
- The AxoGen 52-week high stock price is 15.23, which is 8.8% above the current share price.
- The AxoGen 52-week low stock price is 3.92, which is 72% below the current share price.
- The average AxoGen stock price for the last 52 weeks is 9.03.
AxoGen Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 9.4860 | 6.9100 | 14.7100 | 5.6700 | 14.0000 | 104.98% |
2023 | 7.7263 | 9.8800 | 10.9500 | 3.6100 | 6.8300 | -31.56% |
2022 | 9.5826 | 9.9800 | 13.0900 | 6.9900 | 9.9800 | 6.51% |
2021 | 17.4408 | 17.5100 | 23.5000 | 8.8000 | 9.3700 | -47.65% |
2020 | 12.0044 | 17.3400 | 17.9600 | 7.3450 | 17.9000 | 0.06% |
2019 | 17.7071 | 20.6300 | 25.4700 | 11.1800 | 17.8900 | -12.43% |
2018 | 37.4970 | 27.9500 | 55.9000 | 17.0900 | 20.4300 | -27.81% |
2017 | 16.0429 | 8.9000 | 28.6000 | 8.8000 | 28.3000 | 214.44% |
2016 | 6.8839 | 5.0500 | 9.3600 | 4.6100 | 9.0000 | 80.00% |
2015 | 3.9119 | 3.6000 | 5.6400 | 3.0200 | 5.0000 | 39.28% |
2014 | 3.0089 | 4.8100 | 4.8600 | 2.1500 | 3.5900 | -20.04% |
2013 | 4.0078 | 2.7500 | 5.0800 | 2.7500 | 4.4900 | 66.30% |
2012 | 2.9554 | 2.6000 | 3.9900 | 2.2500 | 2.7000 | 0.00% |
2011 | 2.7243 | 4.0000 | 4.0000 | 2.0000 | 2.7000 | -22.64% |
2010 | 3.5169 | 3.3955 | 5.1627 | 2.7000 | 3.4900 | 6.11% |
2009 | 3.3106 | 2.2500 | 4.6227 | 1.6364 | 3.2891 | 46.18% |
2008 | 2.3995 | 1.0636 | 4.0909 | 1.0636 | 2.2500 | 111.55% |
2007 | 1.8761 | 0.6955 | 6.1364 | 0.4500 | 1.0636 | 100.00% |
2006 | 0.3745 | 0.4173 | 0.6545 | 0.1964 | 0.5318 | 27.44% |
2005 | 1.1510 | 1.1961 | 2.3523 | 0.4173 | 0.4173 | -65.11% |
2004 | 0.9060 | 0.5582 | 1.4353 | 0.4784 | 1.1961 | 85.18% |
2003 | 0.3866 | 0.3907 | 0.7894 | 0.2073 | 0.6459 | 58.81% |
2002 | 0.7809 | 1.2997 | 2.3012 | 0.1834 | 0.4067 | -60.77% |
2001 | 1.4808 | 1.4991 | 2.2725 | 0.8054 | 1.0366 | -30.67% |
2000 | 2.0759 | 1.1961 | 3.9622 | 0.7974 | 1.4951 | 15.39% |
1999 | 2.1898 | 2.0437 | 3.2398 | 1.0470 | 1.2957 | -38.10% |
1998 | 3.0817 | 4.3856 | 4.5849 | 1.8938 | 2.0931 | -48.78% |
1997 | 5.0524 | 5.3823 | 7.1764 | 3.5882 | 4.0866 | -29.31% |
1996 | 8.1252 | 8.7712 | 12.1601 | 4.7843 | 5.7810 | -34.09% |
1995 | 8.3717 | 6.0800 | 11.3627 | 5.7810 | 8.7712 | 51.72% |
1994 | 7.1290 | 7.5751 | 8.5718 | 5.3823 | 5.7810 | -30.95% |
1993 | 8.5982 | 9.1699 | 9.9673 | 7.1764 | 8.3725 | -6.67% |
1992 | 8.2522 | 8.5718 | 11.1633 | 5.7810 | 8.9705 | 1.08% |
1991 | 6.8816 | 2.7908 | 12.1601 | 2.3921 | 8.8748 | 218.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.611B | $0.159B |
AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $213.123B | 26.03 |
Intuitive Surgical (ISRG) | United States | $180.348B | 94.29 |
Alcon (ALC) | Switzerland | $45.275B | 31.87 |
Edwards Lifesciences (EW) | United States | $40.686B | 25.30 |
IQVIA Holdings (IQV) | United States | $38.130B | 20.92 |
IDEXX Laboratories (IDXX) | United States | $34.345B | 40.24 |
DexCom (DXCM) | United States | $27.478B | 41.38 |
Waters (WAT) | United States | $22.986B | 34.00 |
STERIS (STE) | Ireland | $22.207B | 25.91 |
SONOVA HOLDING (SONVY) | Switzerland | $21.889B | 0.00 |
Hologic (HOLX) | United States | $19.123B | 20.79 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.596B | 13.00 |
Sysmex ADR (SSMXY) | Japan | $11.505B | 36.08 |
Globus Medical (GMED) | United States | $10.139B | 28.36 |
Teleflex (TFX) | United States | $9.952B | 15.65 |
Penumbra (PEN) | United States | $8.954B | 87.71 |
Masimo (MASI) | United States | $7.672B | 41.09 |
Glaukos (GKOS) | United States | $7.241B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $4.816B | 0.00 |
Integer Holdings (ITGR) | United States | $4.241B | 24.04 |
Inari Medical (NARI) | United States | $2.853B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.776B | 16.03 |
TransMedics (TMDX) | United States | $2.766B | 87.66 |
Veracyte (VCYT) | United States | $2.635B | 163.38 |
Nihon Kohden (NHNKY) | Japan | $2.558B | 15.91 |
Elekta AB (EKTAY) | Sweden | $2.267B | 18.47 |
Tandem Diabetes Care (TNDM) | United States | $2.089B | 0.00 |
RxSight (RXST) | United States | $1.890B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.496B | 6.81 |
Alphatec Holdings (ATEC) | United States | $1.150B | 0.00 |
Artivion (AORT) | United States | $1.121B | 102.88 |
OPKO Health (OPK) | United States | $1.053B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.896B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.860B | 14.62 |
Pacific Biosciences Of California (PACB) | United States | $0.665B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.663B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.647B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.638B | 16.12 |
IRadimed (IRMD) | United States | $0.612B | 33.08 |
SiBone (SIBN) | United States | $0.562B | 0.00 |
Paragon 28 (FNA) | United States | $0.470B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.356B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.349B | 10.64 |
Treace Medical Concepts (TMCI) | United States | $0.297B | 0.00 |
CVRx (CVRX) | United States | $0.292B | 0.00 |
Delcath Systems (DCTH) | United States | $0.292B | 0.00 |
AngioDynamics (ANGO) | United States | $0.271B | 0.00 |
Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
Semler Scientific (SMLR) | United States | $0.215B | 15.04 |
Nevro (NVRO) | United States | $0.206B | 0.00 |
Inogen (INGN) | United States | $0.206B | 0.00 |
NeuroPace (NPCE) | United States | $0.184B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.179B | 0.00 |
Accuray (ARAY) | United States | $0.175B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.124B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.123B | 0.00 |
908 Devices (MASS) | United States | $0.120B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.108B | 16.02 |
EDAP TMS S.A (EDAP) | France | $0.106B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.088B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.080B | 0.00 |
Hyperfine (HYPR) | United States | $0.071B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.067B | 0.00 |
LENSAR (LNSR) | United States | $0.062B | 0.00 |
InspireMD (NSPR) | Israel | $0.062B | 0.00 |
Envoy Medical (COCH) | United States | $0.050B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.047B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.046B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.045B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
Neuronetics (STIM) | United States | $0.031B | 0.00 |
DarioHealth (DRIO) | United States | $0.030B | 0.00 |
Spectral AI (MDAI) | United States | $0.027B | 0.00 |
Precision Optics (POCI) | United States | $0.026B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
NexGel (NXGL) | United States | $0.018B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.017B | 0.00 | |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.013B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.013B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |